Tarek Dakakni: Mobile Stroke Units Make Treatment Faster, Clearer, and Smarter
Tarek Dakakni, Medical Director Neurosciences at Northeast Georgia Health System (NGHS), shared on LinkedIn:
”Innovation is making stroke care faster, clearer, and smarter.
Now we have to train our systems to keep up.
Technology is no longer the barrier. I think that adoption is.
If we want to save more brain with faster stroke treatment, we must align EMS, nurses, stroke teams, and leaders around one idea: Bring care to the patient, not the patient to the care.
Years ago, when I saw a portable CT scanner roll into a critically ill patient’s room for the first time, no transport team, no elevators, no delays, I started thinking, why move a fragile brain to technology when we can move technology to the brain?
That philosophy is now real in the field through the Mobile Stroke Unit (MSU).
In 2026, new ASA/AHA recommendations formally recognize MSUs as improving outcomes by shortening time to diagnosis and treatment.
A Mobile Stroke Unit is a mini primary stroke center on wheels:
- On-board CT
- Tele-neurology
- Point-of-care labs
- Immediate thrombolytics treatment for eligible patients
Tenecteplase, which is now officially endorsed, makes this even faster.
Unlike alteplase, tenecteplase is a single IV bolus, not a one hour infusion.
That means stroke treatment can begin immediately in the field, not after hospital arrival.
Smarter triage. Faster intervention.
With MSU diagnosis and treatment:
Instead of Home to Primary Stroke Center to Transfer
We can move directly to Home to MSU treatment to Thrombectomy-capable or Comprehensive Stroke Center
This:
- Saves time, therefore, more eligible patients
- Preserves more neurons
- Reduces cost
- Expands access to thrombectomy and thrombolysis
And for hemorrhage?
MSUs allow us to:
- Diagnose intracranial hemorrhage immediately, and triage accordingly
- Start targeted blood pressure control
- Reduce risk of hematoma expansion before hospital arrival
The future is already here.
Portable MRI, AI-driven imaging, and rapid diagnostics are emerging to make bedside stroke diagnosis faster and more precise than ever.
This is not replacing clinicians.
It is amplifying us, helping to make treatment more efficient and faster, which is essential in stroke care.
Now, and more than ever, I’m very excited about the future of stroke care, where innovation, AI, and mobile technology make us faster, safer, and more human.
The question is: What would it take for any system to fully embrace this future?
Because every minute we save is not just brain, it’s life, identity, and independence.”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?